Purvalanol a
- CAS No.
- 212844-53-6
- Chemical Name:
- Purvalanol a
- Synonyms
- NG-60;PurvaL;CH61386;CS-1631;CDKinhibitor;Purvalanol a;(R)-Purvalanol A;NG 60;NG60;NG-60;PURVALANOLA, >98%;Purvalanol A(NG 60)
- CBNumber:
- CB5283664
- Molecular Formula:
- C19H25ClN6O
- Molecular Weight:
- 388.89
- MDL Number:
- MFCD02179211
- MOL File:
- 212844-53-6.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 590.5±60.0 °C(Predicted) |
|---|---|
| Density | 1.33±0.1 g/cm3(Predicted) |
| storage temp. | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
| solubility | methylene chloride: 50 mg/mL, clear, colorless |
| form | powder |
| pka | 14.51±0.10(Predicted) |
| color | off-white |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
| InChI | 1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1 |
| InChIKey | PMXCMJLOPOFPBT-HNNXBMFYSA-N |
| SMILES | Clc1cc(ccc1)Nc2nc(nc3[n](cnc32)C(C)C)N[C@@H](CO)C(C)C |
| FDA UNII | YP483E75C4 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P271-P261-P280 |
| WGK Germany | 3 |
| HS Code | 2933599590 |
| Storage Class | 11 - Combustible Solids |
Purvalanol a price More Price(74)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 540500 | Purvalanol A | 212844-53-6 | 1mg | $124 | 2026-04-30 | Buy |
| Sigma-Aldrich | P4484 | Purvalanol A ≥98% (HPLC), powder | 212844-53-6 | 1mg | $144 | 2023-06-20 | Buy |
| Cayman Chemical | 14579 | Purvalanol A ≥98% | 212844-53-6 | 5mg | $36 | 2026-04-30 | Buy |
| Cayman Chemical | 14579 | Purvalanol A ≥98% | 212844-53-6 | 10mg | $68 | 2026-04-30 | Buy |
| Cayman Chemical | 14579 | Purvalanol A ≥98% | 212844-53-6 | 50mg | $303 | 2026-04-30 | Buy |
Purvalanol a Chemical Properties, Uses, Production
Description
Purvalanol A (212844-53-6) is a cyclin-dependent kinase inhibitor. IC50s= 4, 70, 35, 75 and 850 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk5/p35 and cdk4/cyclin D1 and respectively.1Reversibly arrests synchronized cells in G1 and G2 phase.2Induces ER stress-mediated apoptosis and autophagy in colon cancer cells.3Suppresses Src-mediated transformation by inhibiting both CDKs and c-Src.4In cells transformed with MYC, purvalanol A rapidly down-regulates survivin expression and induces MYC-dependent apoptosis.5Cell permeable.
Uses
Purvalanol A acts as a potent, cell-permeable CDK inhibitor used in the treatment of cell proliferative disorders. Anti-cancer.
Definition
ChEBI: Purvalanol A is a purvalanol.
Biological Activity
Cyclin-dependent kinase inhibitor. IC 50 values are 4, 70, 35, 850 and 75 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, cdk4/cyclin D1 and cdk5-p35 respectively. Reversibly arrests synchronised cells in G1 and G2, and inhibits cell proliferation and cell death.
storage
Store at +4°C
References
[1] SERA T. [Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors].[J]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 2007, 52 13 Suppl: 1812-1813.
[2] NATHALIE VILLERBU. Cellular effects of purvalanol A: A specific inhibitor of cyclin-dependent kinase activities[J]. International Journal of Cancer, 2001, 97 6: 761-769. DOI:10.1002/ijc.10125
[3] AJDA COKER-GÜRKAN. Purvalanol induces endoplasmic reticulum stress-mediated apoptosis and autophagy in a time-dependent manner in HCT116 colon cancer cells.[J]. Oncology reports, 2015: 2761-2770. DOI:10.3892/or.2015.3918
[4] TOMOYA HIKITA Masato O Chitose Oneyama. Purvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src.[J]. Genes to Cells, 2010, 15 10: 1051-1062. DOI:10.1111/j.1365-2443.2010.01439.x
[5] ANDREI GOGA. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC[J]. Nature Medicine, 2007, 13 7: 820-827. DOI:10.1038/nm1606
Purvalanol a Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2915 | 55 | |
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| Ascent Scientific | 4401179829988 | customerservice@ascentscientific.co.uk | United Kingdom | 279 | 60 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4853 | 58 |
| Bide Pharmatech Ltd. | 400-164-7117 18317119277 | product02@bidepharm.com | China | 40000 | 60 |
| AdooQ Bioscience CHINA | 025-58849295 | info@adooq.cn | China | 2981 | 60 |
| Shanghai JiYi Biotechnology Co. Ltd. | 13621943973 | sales@shjiyipharmatech.com | China | 1166 | 55 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4860 | 55 | |
| Shanghaizehan biopharma technology co., Ltd. | 021-61350663 13052117465 | sales@zehanbiopharma.com | China | 989 | 55 |
View Latest Price from Purvalanol a manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Purvalanol A
212844-53-6
|
$33.00-77.00 | 99.68% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2019-09-06 | PURVALANOL A
212844-53-6
|
$1.00 | 1KG | 98% | 20kg | Career Henan Chemical Co |
-

- Purvalanol A
212844-53-6
- $33.00-77.00
- 99.68%
- TargetMol Chemicals Inc.
-

- PURVALANOL A
212844-53-6
- $1.00
- 98%
- Career Henan Chemical Co
212844-53-6 (Purvalanol a) Related Search:
1of4





